GoodRX | GDRX | Long at $5.00

GoodRX | GDRX | Long at $5.00

GoodRX NASDAQ:GDRX . Going long at $5.00.

Pros:

Revenue is growing and is expected to reach almost $1 billion by 2027
Debt-to-equity = 0.71x (low)
Monthly active users continue to increase (+7% during Q3 of 2024)
From a technical analysis perspective, the downward trend is starting to reverse, and the price has connected with my historical simple moving average (likely leading to a price increase)


Cons:

Not yet profitable
A lot of market competition
Insiders exercising of options outweighs awarding of options
No dividend


Targets:

$6.00
$7.00
$8.00
Substantially higher if partnerships emerge and profitability begins


Read More

Share:

Latest News